| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 1.18e-07 | 749 | 18 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.44e-07 | 188 | 18 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.01e-05 | 156 | 18 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.25e-05 | 51 | 18 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | integrin binding | 1.58e-05 | 175 | 18 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 8.37e-05 | 268 | 18 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 9.14e-05 | 16 | 18 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.44e-04 | 20 | 18 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.60e-04 | 21 | 18 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.72e-04 | 323 | 18 | 4 | GO:1901681 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 2.46e-04 | 26 | 18 | 2 | GO:0050431 | |
| GeneOntologyMolecularFunction | fibronectin binding | 5.29e-04 | 38 | 18 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 5.58e-04 | 39 | 18 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | heparin binding | 6.42e-04 | 192 | 18 | 3 | GO:0008201 | |
| GeneOntologyMolecularFunction | structural molecule activity | 9.22e-04 | 891 | 18 | 5 | GO:0005198 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.75e-03 | 599 | 18 | 4 | GO:0050839 | |
| GeneOntologyMolecularFunction | coreceptor activity | 1.89e-03 | 72 | 18 | 2 | GO:0015026 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.94e-03 | 73 | 18 | 2 | GO:0050840 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 2.62e-03 | 85 | 18 | 2 | GO:0038024 | |
| GeneOntologyMolecularFunction | cytokine binding | 8.65e-03 | 157 | 18 | 2 | GO:0019955 | |
| GeneOntologyMolecularFunction | protease binding | 1.14e-02 | 181 | 18 | 2 | GO:0002020 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 5.38e-08 | 445 | 18 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 9.28e-08 | 482 | 18 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | response to growth factor | 3.26e-07 | 883 | 18 | 8 | GO:0070848 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.40e-07 | 347 | 18 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 9.28e-07 | 412 | 18 | 6 | GO:0090287 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 3.04e-06 | 1186 | 18 | 8 | GO:0007167 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 3.07e-06 | 276 | 18 | 5 | GO:0007179 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 4.21e-06 | 850 | 18 | 7 | GO:0071363 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 5.40e-06 | 40 | 18 | 3 | GO:0097242 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 7.18e-06 | 5 | 18 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 7.18e-06 | 5 | 18 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 7.60e-06 | 150 | 18 | 4 | GO:0090288 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 8.01e-06 | 336 | 18 | 5 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 8.86e-06 | 343 | 18 | 5 | GO:0071559 | |
| GeneOntologyBiologicalProcess | negative regulation of endothelial cell chemotaxis | 1.51e-05 | 7 | 18 | 2 | GO:2001027 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 1.51e-05 | 7 | 18 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | renal system development | 1.57e-05 | 386 | 18 | 5 | GO:0072001 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 2.01e-05 | 8 | 18 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 2.01e-05 | 192 | 18 | 4 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 2.14e-05 | 195 | 18 | 4 | GO:1903844 | |
| GeneOntologyBiologicalProcess | heart development | 3.05e-05 | 757 | 18 | 6 | GO:0007507 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 3.22e-05 | 10 | 18 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.31e-05 | 218 | 18 | 4 | GO:0090101 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 3.48e-05 | 74 | 18 | 3 | GO:0010812 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 4.40e-05 | 80 | 18 | 3 | GO:0030514 | |
| GeneOntologyBiologicalProcess | aorta development | 4.40e-05 | 80 | 18 | 3 | GO:0035904 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 4.72e-05 | 12 | 18 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 4.91e-05 | 83 | 18 | 3 | GO:0060976 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 6.51e-05 | 14 | 18 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 6.68e-05 | 92 | 18 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 7.12e-05 | 94 | 18 | 3 | GO:0003151 | |
| GeneOntologyBiologicalProcess | negative regulation of focal adhesion assembly | 9.71e-05 | 17 | 18 | 2 | GO:0051895 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate junction organization | 9.71e-05 | 17 | 18 | 2 | GO:0150118 | |
| GeneOntologyBiologicalProcess | tube development | 1.08e-04 | 1402 | 18 | 7 | GO:0035295 | |
| GeneOntologyBiologicalProcess | axon development | 1.76e-04 | 642 | 18 | 5 | GO:0061564 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 1.91e-04 | 131 | 18 | 3 | GO:0030510 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 1.96e-04 | 24 | 18 | 2 | GO:1905146 | |
| GeneOntologyBiologicalProcess | transcytosis | 1.96e-04 | 24 | 18 | 2 | GO:0045056 | |
| GeneOntologyBiologicalProcess | artery development | 1.99e-04 | 133 | 18 | 3 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 2.04e-04 | 134 | 18 | 3 | GO:0003279 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell chemotaxis | 2.31e-04 | 26 | 18 | 2 | GO:2001026 | |
| GeneOntologyBiologicalProcess | kidney development | 2.61e-04 | 372 | 18 | 4 | GO:0001822 | |
| GeneOntologyBiologicalProcess | lipoprotein transport | 2.68e-04 | 28 | 18 | 2 | GO:0042953 | |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 2.68e-04 | 28 | 18 | 2 | GO:0007039 | |
| GeneOntologyBiologicalProcess | pericardium development | 2.68e-04 | 28 | 18 | 2 | GO:0060039 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 2.69e-04 | 375 | 18 | 4 | GO:0007162 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 2.73e-04 | 148 | 18 | 3 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 2.73e-04 | 148 | 18 | 3 | GO:0035113 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 2.73e-04 | 1125 | 18 | 6 | GO:0035239 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell differentiation | 2.88e-04 | 29 | 18 | 2 | GO:0090335 | |
| GeneOntologyBiologicalProcess | lipoprotein localization | 2.88e-04 | 29 | 18 | 2 | GO:0044872 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 2.91e-04 | 383 | 18 | 4 | GO:0048608 | |
| GeneOntologyBiologicalProcess | reproductive system development | 3.06e-04 | 388 | 18 | 4 | GO:0061458 | |
| GeneOntologyBiologicalProcess | prostate gland epithelium morphogenesis | 3.74e-04 | 33 | 18 | 2 | GO:0060740 | |
| GeneOntologyBiologicalProcess | prostate gland morphogenesis | 3.97e-04 | 34 | 18 | 2 | GO:0060512 | |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 3.97e-04 | 34 | 18 | 2 | GO:0060977 | |
| GeneOntologyBiologicalProcess | endothelial cell chemotaxis | 4.21e-04 | 35 | 18 | 2 | GO:0035767 | |
| GeneOntologyBiologicalProcess | embryonic hindlimb morphogenesis | 4.21e-04 | 35 | 18 | 2 | GO:0035116 | |
| GeneOntologyBiologicalProcess | heart formation | 4.45e-04 | 36 | 18 | 2 | GO:0060914 | |
| GeneOntologyBiologicalProcess | growth | 4.53e-04 | 1235 | 18 | 6 | GO:0040007 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 5.23e-04 | 1269 | 18 | 6 | GO:0009887 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 5.25e-04 | 185 | 18 | 3 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 5.25e-04 | 185 | 18 | 3 | GO:0035108 | |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 5.78e-04 | 41 | 18 | 2 | GO:1901889 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 5.78e-04 | 41 | 18 | 2 | GO:0035909 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway | 6.11e-04 | 195 | 18 | 3 | GO:0030178 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 6.30e-04 | 197 | 18 | 3 | GO:0030509 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-matrix adhesion | 6.36e-04 | 43 | 18 | 2 | GO:0001953 | |
| GeneOntologyBiologicalProcess | negative regulation of cell migration involved in sprouting angiogenesis | 7.28e-04 | 46 | 18 | 2 | GO:0090051 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 7.79e-04 | 212 | 18 | 3 | GO:0003205 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 7.92e-04 | 48 | 18 | 2 | GO:0043277 | |
| GeneOntologyBiologicalProcess | response to BMP | 8.12e-04 | 215 | 18 | 3 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 8.12e-04 | 215 | 18 | 3 | GO:0071773 | |
| GeneOntologyBiologicalProcess | hindlimb morphogenesis | 8.26e-04 | 49 | 18 | 2 | GO:0035137 | |
| GeneOntologyBiologicalProcess | negative regulation of ossification | 8.60e-04 | 50 | 18 | 2 | GO:0030279 | |
| GeneOntologyBiologicalProcess | developmental growth | 8.80e-04 | 911 | 18 | 5 | GO:0048589 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 8.90e-04 | 515 | 18 | 4 | GO:0050767 | |
| GeneOntologyBiologicalProcess | chemotaxis | 9.03e-04 | 517 | 18 | 4 | GO:0006935 | |
| GeneOntologyBiologicalProcess | limb development | 9.14e-04 | 224 | 18 | 3 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 9.14e-04 | 224 | 18 | 3 | GO:0048736 | |
| GeneOntologyBiologicalProcess | taxis | 9.16e-04 | 519 | 18 | 4 | GO:0042330 | |
| GeneOntologyBiologicalProcess | negative regulation of chemotaxis | 1.00e-03 | 54 | 18 | 2 | GO:0050922 | |
| GeneOntologyBiologicalProcess | circulatory system development | 1.03e-03 | 1442 | 18 | 6 | GO:0072359 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | 1.09e-03 | 1458 | 18 | 6 | GO:0051247 | |
| GeneOntologyBiologicalProcess | endocardial cushion development | 1.16e-03 | 58 | 18 | 2 | GO:0003197 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 1.19e-03 | 59 | 18 | 2 | GO:0085029 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue morphogenesis | 1.19e-03 | 59 | 18 | 2 | GO:0055010 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.26e-03 | 566 | 18 | 4 | GO:0007409 | |
| GeneOntologyBiologicalProcess | regeneration | 1.28e-03 | 252 | 18 | 3 | GO:0031099 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 1.31e-03 | 254 | 18 | 3 | GO:0010810 | |
| GeneOntologyBiologicalProcess | prostate gland development | 1.32e-03 | 62 | 18 | 2 | GO:0030850 | |
| GeneOntologyBiologicalProcess | brown fat cell differentiation | 1.54e-03 | 67 | 18 | 2 | GO:0050873 | |
| GeneOntologyBiologicalProcess | lung development | 1.55e-03 | 269 | 18 | 3 | GO:0030324 | |
| GeneOntologyCellularComponent | microfibril | 4.83e-05 | 13 | 17 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.94e-05 | 530 | 17 | 5 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.36e-04 | 656 | 17 | 5 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.37e-04 | 658 | 17 | 5 | GO:0030312 | |
| GeneOntologyCellularComponent | cell surface | 1.66e-04 | 1111 | 17 | 6 | GO:0009986 | |
| GeneOntologyCellularComponent | side of membrane | 5.16e-04 | 875 | 17 | 5 | GO:0098552 | |
| GeneOntologyCellularComponent | axonal growth cone | 6.04e-04 | 45 | 17 | 2 | GO:0044295 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 6.91e-04 | 519 | 17 | 4 | GO:0009897 | |
| GeneOntologyCellularComponent | receptor complex | 1.05e-03 | 581 | 17 | 4 | GO:0043235 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.90e-03 | 80 | 17 | 2 | GO:0005905 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.29e-03 | 332 | 17 | 3 | GO:0005788 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 3.11e-03 | 1307 | 17 | 5 | GO:0030659 | |
| GeneOntologyCellularComponent | vesicle membrane | 3.31e-03 | 1325 | 17 | 5 | GO:0012506 | |
| GeneOntologyCellularComponent | basement membrane | 4.34e-03 | 122 | 17 | 2 | GO:0005604 | |
| GeneOntologyCellularComponent | postsynaptic density | 5.42e-03 | 451 | 17 | 3 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 6.33e-03 | 477 | 17 | 3 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 7.08e-03 | 157 | 17 | 2 | GO:0098839 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 7.32e-03 | 503 | 17 | 3 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 8.15e-03 | 523 | 17 | 3 | GO:0098984 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.10e-02 | 583 | 17 | 3 | GO:0097060 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.14e-02 | 201 | 17 | 2 | GO:0099634 | |
| GeneOntologyCellularComponent | apical part of cell | 1.14e-02 | 592 | 17 | 3 | GO:0045177 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.26e-02 | 212 | 17 | 2 | GO:0030666 | |
| GeneOntologyCellularComponent | endosome | 1.28e-02 | 1167 | 17 | 4 | GO:0005768 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 1.56e-02 | 237 | 17 | 2 | GO:0030136 | |
| HumanPheno | Microspherophakia | 2.08e-05 | 4 | 10 | 2 | HP:0030961 | |
| HumanPheno | Iridodonesis | 3.46e-05 | 5 | 10 | 2 | HP:0100693 | |
| HumanPheno | Spherophakia | 3.46e-05 | 5 | 10 | 2 | HP:0034375 | |
| HumanPheno | Pulmonic stenosis | 9.54e-05 | 138 | 10 | 4 | HP:0001642 | |
| HumanPheno | Abnormal pulmonary valve physiology | 1.83e-04 | 163 | 10 | 4 | HP:0031654 | |
| HumanPheno | Short finger | 1.98e-04 | 325 | 10 | 5 | HP:0009381 | |
| HumanPheno | Cardiac valve calcification | 2.67e-04 | 13 | 10 | 2 | HP:0005146 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 3.47e-04 | 366 | 10 | 5 | HP:0006265 | |
| HumanPheno | Aplasia/Hypoplasia of the lens | 3.59e-04 | 15 | 10 | 2 | HP:0008063 | |
| HumanPheno | Abnormal pulmonary valve morphology | 3.87e-04 | 198 | 10 | 4 | HP:0001641 | |
| MousePheno | overexpanded pulmonary alveolus | 7.60e-06 | 37 | 15 | 3 | MP:0001183 | |
| MousePheno | emphysema | 7.60e-06 | 37 | 15 | 3 | MP:0001958 | |
| MousePheno | abnormal heart ventricle morphology | 7.93e-06 | 793 | 15 | 7 | MP:0005294 | |
| MousePheno | heart right ventricle hypertrophy | 1.12e-05 | 42 | 15 | 3 | MP:0000276 | |
| MousePheno | abnormal heart right ventricle wall morphology | 2.14e-05 | 52 | 15 | 3 | MP:0031534 | |
| MousePheno | increased heart right ventricle size | 2.54e-05 | 55 | 15 | 3 | MP:0010563 | |
| MousePheno | abnormal heart septum morphology | 3.83e-05 | 388 | 15 | 5 | MP:0006113 | |
| MousePheno | increased aorta wall thickness | 3.85e-05 | 9 | 15 | 2 | MP:0010996 | |
| MousePheno | abnormal muscle morphology | 6.95e-05 | 1106 | 15 | 7 | MP:0002108 | |
| MousePheno | abnormal artery morphology | 6.98e-05 | 440 | 15 | 5 | MP:0002191 | |
| MousePheno | abnormal lung vasculature morphology | 7.25e-05 | 78 | 15 | 3 | MP:0004007 | |
| MousePheno | abnormal heart right ventricle size | 7.25e-05 | 78 | 15 | 3 | MP:0010577 | |
| MousePheno | abnormal aorta morphology | 7.76e-05 | 225 | 15 | 4 | MP:0000272 | |
| MousePheno | abnormal lung morphology | 8.73e-05 | 767 | 15 | 6 | MP:0001175 | |
| MousePheno | abnormal aorta elastic fiber morphology | 9.71e-05 | 14 | 15 | 2 | MP:0003211 | |
| MousePheno | small embryonic telencephalon | 1.12e-04 | 15 | 15 | 2 | MP:0000936 | |
| MousePheno | abnormal limb bud morphology | 1.15e-04 | 91 | 15 | 3 | MP:0005650 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 1.15e-04 | 489 | 15 | 5 | MP:0010630 | |
| MousePheno | abnormal pulmonary alveolus morphology | 1.26e-04 | 255 | 15 | 4 | MP:0002270 | |
| MousePheno | atelectasis | 1.91e-04 | 108 | 15 | 3 | MP:0001177 | |
| MousePheno | abnormal dermal layer morphology | 1.91e-04 | 108 | 15 | 3 | MP:0001243 | |
| MousePheno | abnormal pulmonary acinus morphology | 1.91e-04 | 284 | 15 | 4 | MP:0010911 | |
| MousePheno | abnormal respiratory system physiology | 2.08e-04 | 897 | 15 | 6 | MP:0002133 | |
| MousePheno | abnormal pulmonary alveolar system morphology | 2.24e-04 | 296 | 15 | 4 | MP:0010899 | |
| MousePheno | abnormal aorta elastic tissue morphology | 2.45e-04 | 22 | 15 | 2 | MP:0009862 | |
| MousePheno | abnormal systemic artery morphology | 2.48e-04 | 304 | 15 | 4 | MP:0011655 | |
| MousePheno | abnormal blood vessel elastic tissue morphology | 2.93e-04 | 24 | 15 | 2 | MP:0006083 | |
| MousePheno | abnormal spine curvature | 2.94e-04 | 318 | 15 | 4 | MP:0004174 | |
| MousePheno | increased lung compliance | 3.44e-04 | 26 | 15 | 2 | MP:0010895 | |
| MousePheno | abnormal bone trabecula morphology | 3.60e-04 | 134 | 15 | 3 | MP:0010867 | |
| MousePheno | abnormal thoracic aorta morphology | 3.60e-04 | 134 | 15 | 3 | MP:0010468 | |
| MousePheno | abnormal trabecular bone connectivity density | 3.71e-04 | 27 | 15 | 2 | MP:0010931 | |
| MousePheno | abnormal interventricular septum morphology | 3.88e-04 | 342 | 15 | 4 | MP:0000281 | |
| MousePheno | abnormal axial skeleton morphology | 4.00e-04 | 1458 | 15 | 7 | MP:0002114 | |
| MousePheno | abnormal limb development | 4.10e-04 | 140 | 15 | 3 | MP:0006279 | |
| MousePheno | diaphragmatic hernia | 4.29e-04 | 29 | 15 | 2 | MP:0003924 | |
| MousePheno | abnormal respiratory system morphology | 4.35e-04 | 1027 | 15 | 6 | MP:0002132 | |
| MousePheno | abnormal heart valve physiology | 4.59e-04 | 30 | 15 | 2 | MP:0011926 | |
| MousePheno | hemorrhage | 4.80e-04 | 664 | 15 | 5 | MP:0001914 | |
| MousePheno | abnormal tendon morphology | 4.91e-04 | 31 | 15 | 2 | MP:0005503 | |
| MousePheno | abnormal heart left ventricle morphology | 5.18e-04 | 369 | 15 | 4 | MP:0003921 | |
| MousePheno | brachydactyly | 5.57e-04 | 33 | 15 | 2 | MP:0002544 | |
| MousePheno | abnormal heart right ventricle morphology | 5.62e-04 | 156 | 15 | 3 | MP:0003920 | |
| MousePheno | internal hemorrhage | 6.20e-04 | 387 | 15 | 4 | MP:0001634 | |
| MousePheno | abnormal bronchiole morphology | 7.00e-04 | 37 | 15 | 2 | MP:0002267 | |
| MousePheno | abnormal metacarpal bone morphology | 7.00e-04 | 37 | 15 | 2 | MP:0003073 | |
| MousePheno | decreased respiration | 7.22e-04 | 170 | 15 | 3 | MP:0014274 | |
| MousePheno | abnormal bone volume | 7.60e-04 | 173 | 15 | 3 | MP:0010874 | |
| MousePheno | abnormal aorta tunica media morphology | 7.78e-04 | 39 | 15 | 2 | MP:0009873 | |
| MousePheno | increased heart ventricle size | 7.85e-04 | 175 | 15 | 3 | MP:0008772 | |
| MousePheno | abnormal myocardium layer morphology | 7.98e-04 | 414 | 15 | 4 | MP:0005329 | |
| MousePheno | abnormal heart layer morphology | 8.58e-04 | 422 | 15 | 4 | MP:0010545 | |
| MousePheno | abnormal lung compliance | 9.03e-04 | 42 | 15 | 2 | MP:0002333 | |
| MousePheno | abnormal heart size | 9.17e-04 | 1180 | 15 | 6 | MP:0005406 | |
| MousePheno | small pharyngeal arch | 9.91e-04 | 44 | 15 | 2 | MP:0006346 | |
| MousePheno | abnormal vertebral column morphology | 1.04e-03 | 787 | 15 | 5 | MP:0004703 | |
| MousePheno | trabecula carnea hypoplasia | 1.08e-03 | 46 | 15 | 2 | MP:0000295 | |
| MousePheno | cardiac hypertrophy | 1.09e-03 | 196 | 15 | 3 | MP:0001625 | |
| MousePheno | abnormal bone trabecular spacing | 1.18e-03 | 48 | 15 | 2 | MP:0013629 | |
| MousePheno | abnormal aorta wall morphology | 1.28e-03 | 50 | 15 | 2 | MP:0009866 | |
| MousePheno | narrow eye opening | 1.28e-03 | 50 | 15 | 2 | MP:0005287 | |
| MousePheno | abnormal ear morphology | 1.28e-03 | 470 | 15 | 4 | MP:0002102 | |
| MousePheno | limbs/digits/tail phenotype | 1.29e-03 | 1258 | 15 | 6 | MP:0005371 | |
| MousePheno | lung hemorrhage | 1.38e-03 | 52 | 15 | 2 | MP:0001182 | |
| MousePheno | lordosis | 1.38e-03 | 52 | 15 | 2 | MP:0000162 | |
| MousePheno | omphalocele | 1.43e-03 | 53 | 15 | 2 | MP:0003052 | |
| MousePheno | abnormal blood circulation | 1.44e-03 | 845 | 15 | 5 | MP:0002128 | |
| MousePheno | respiratory system inflammation | 1.52e-03 | 220 | 15 | 3 | MP:0002405 | |
| MousePheno | abnormal pulmonary interalveolar septum morphology | 1.54e-03 | 55 | 15 | 2 | MP:0010900 | |
| MousePheno | abnormal trigeminal ganglion morphology | 1.54e-03 | 55 | 15 | 2 | MP:0001092 | |
| MousePheno | distended pericardium | 1.54e-03 | 55 | 15 | 2 | MP:0000292 | |
| MousePheno | impaired hearing | 1.58e-03 | 223 | 15 | 3 | MP:0006325 | |
| MousePheno | abnormal pericardium morphology | 1.62e-03 | 225 | 15 | 3 | MP:0000288 | |
| MousePheno | abnormal skin condition | 1.66e-03 | 227 | 15 | 3 | MP:0001191 | |
| MousePheno | abnormal heart ventricle size | 1.69e-03 | 228 | 15 | 3 | MP:0031543 | |
| MousePheno | kyphosis | 1.71e-03 | 229 | 15 | 3 | MP:0000160 | |
| MousePheno | myocardial trabeculae hypoplasia | 1.72e-03 | 58 | 15 | 2 | MP:0010503 | |
| MousePheno | abnormal neutrophil morphology | 1.75e-03 | 511 | 15 | 4 | MP:0005065 | |
| MousePheno | abnormal eyelid aperture | 1.78e-03 | 59 | 15 | 2 | MP:0003671 | |
| MousePheno | abnormal jaw morphology | 2.00e-03 | 530 | 15 | 4 | MP:0000454 | |
| MousePheno | abnormal posture | 2.02e-03 | 243 | 15 | 3 | MP:0001504 | |
| MousePheno | craniofacial phenotype | 2.03e-03 | 1372 | 15 | 6 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 2.03e-03 | 1372 | 15 | 6 | MP:0000428 | |
| Domain | EGF_3 | 3.29e-15 | 235 | 18 | 10 | PS50026 | |
| Domain | EGF-like_dom | 5.90e-15 | 249 | 18 | 10 | IPR000742 | |
| Domain | EGF_CA | 6.10e-15 | 86 | 18 | 8 | PF07645 | |
| Domain | EGF_1 | 7.50e-15 | 255 | 18 | 10 | PS00022 | |
| Domain | EGF-like_CS | 9.48e-15 | 261 | 18 | 10 | IPR013032 | |
| Domain | EGF_2 | 1.11e-14 | 265 | 18 | 10 | PS01186 | |
| Domain | EGF_CA | 1.09e-13 | 122 | 18 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.24e-13 | 124 | 18 | 8 | IPR001881 | |
| Domain | EGF | 2.99e-13 | 235 | 18 | 9 | SM00181 | |
| Domain | Growth_fac_rcpt_ | 8.06e-13 | 156 | 18 | 8 | IPR009030 | |
| Domain | EGF_Ca-bd_CS | 2.48e-12 | 97 | 18 | 7 | IPR018097 | |
| Domain | EGF_CA | 2.88e-12 | 99 | 18 | 7 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.09e-12 | 100 | 18 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.69e-12 | 106 | 18 | 7 | IPR000152 | |
| Domain | EGF | 1.45e-09 | 126 | 18 | 6 | PF00008 | |
| Domain | cEGF | 8.91e-09 | 26 | 18 | 4 | PF12662 | |
| Domain | cEGF | 8.91e-09 | 26 | 18 | 4 | IPR026823 | |
| Domain | TB | 2.62e-08 | 7 | 18 | 3 | PF00683 | |
| Domain | - | 4.20e-08 | 8 | 18 | 3 | 3.90.290.10 | |
| Domain | TB_dom | 6.29e-08 | 9 | 18 | 3 | IPR017878 | |
| Domain | TB | 6.29e-08 | 9 | 18 | 3 | PS51364 | |
| Domain | Ldl_recept_b | 2.72e-07 | 14 | 18 | 3 | PF00058 | |
| Domain | LDLRB | 2.72e-07 | 14 | 18 | 3 | PS51120 | |
| Domain | EGF_extracell | 2.85e-07 | 60 | 18 | 4 | IPR013111 | |
| Domain | EGF_2 | 2.85e-07 | 60 | 18 | 4 | PF07974 | |
| Domain | LY | 3.40e-07 | 15 | 18 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.40e-07 | 15 | 18 | 3 | IPR000033 | |
| Domain | - | 6.72e-06 | 39 | 18 | 3 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 7.26e-06 | 40 | 18 | 3 | IPR023415 | |
| Domain | Ldl_recept_a | 1.04e-05 | 45 | 18 | 3 | PF00057 | |
| Domain | - | 1.11e-05 | 46 | 18 | 3 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.11e-05 | 46 | 18 | 3 | IPR011042 | |
| Domain | LDLRA_1 | 1.27e-05 | 48 | 18 | 3 | PS01209 | |
| Domain | LDLa | 1.35e-05 | 49 | 18 | 3 | SM00192 | |
| Domain | LDLRA_2 | 1.35e-05 | 49 | 18 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.35e-05 | 49 | 18 | 3 | IPR002172 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.76e-07 | 300 | 15 | 6 | M610 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.75e-06 | 32 | 15 | 3 | MM14854 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.11e-06 | 258 | 15 | 5 | MM14572 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 7.41e-06 | 37 | 15 | 3 | M27134 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 8.04e-06 | 38 | 15 | 3 | MM14874 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 8.71e-06 | 39 | 15 | 3 | MM14601 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.17e-05 | 43 | 15 | 3 | M53 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.26e-05 | 44 | 15 | 3 | M26969 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.54e-05 | 47 | 15 | 3 | M646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 2.95e-05 | 8 | 15 | 2 | M47850 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.28e-05 | 66 | 15 | 3 | M18 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.54e-05 | 76 | 15 | 3 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 6.80e-05 | 77 | 15 | 3 | MM14670 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 9.14e-05 | 85 | 15 | 3 | M16441 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.23e-04 | 94 | 15 | 3 | M1041 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 1.42e-04 | 17 | 15 | 2 | M39443 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.42e-04 | 118 | 15 | 3 | MM15588 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 3.13e-04 | 25 | 15 | 2 | M39713 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 3.65e-04 | 27 | 15 | 2 | M27217 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 5.15e-04 | 32 | 15 | 2 | M165 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 6.01e-04 | 161 | 15 | 3 | M27871 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 9.73e-04 | 190 | 15 | 3 | MM15687 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.02e-03 | 45 | 15 | 2 | MM15344 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.16e-03 | 48 | 15 | 2 | M27642 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 1.75e-03 | 59 | 15 | 2 | M46460 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.75e-03 | 59 | 15 | 2 | M27218 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.75e-03 | 59 | 15 | 2 | M39886 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.31e-03 | 68 | 15 | 2 | M27303 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.88e-03 | 76 | 15 | 2 | M27219 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.50e-03 | 84 | 15 | 2 | M7098 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 4.19e-03 | 92 | 15 | 2 | MM14881 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 4.55e-03 | 96 | 15 | 2 | M39581 | |
| Pathway | WP_P53_TRANSCRIPTIONAL_GENE_NETWORK | 4.55e-03 | 96 | 15 | 2 | M40062 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 4.93e-03 | 100 | 15 | 2 | M27158 | |
| Pathway | WP_1P36_COPY_NUMBER_VARIATION_SYNDROME | 6.14e-03 | 112 | 15 | 2 | M48072 | |
| Pathway | WP_BURN_WOUND_HEALING | 6.25e-03 | 113 | 15 | 2 | M42571 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 7.00e-03 | 381 | 15 | 3 | M48063 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 7.02e-03 | 120 | 15 | 2 | MM14982 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 7.48e-03 | 124 | 15 | 2 | M27285 | |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 8.44e-03 | 132 | 15 | 2 | M48110 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 9.84e-03 | 143 | 15 | 2 | M27275 | |
| Pubmed | 4.65e-10 | 4 | 18 | 3 | 7775583 | ||
| Pubmed | 1.16e-09 | 5 | 18 | 3 | 19047013 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.55e-09 | 101 | 18 | 5 | 20551380 | |
| Pubmed | 9.98e-09 | 146 | 18 | 5 | 27068509 | ||
| Pubmed | 1.92e-08 | 11 | 18 | 3 | 24639464 | ||
| Pubmed | 1.96e-08 | 167 | 18 | 5 | 22159717 | ||
| Pubmed | 2.47e-08 | 175 | 18 | 5 | 28071719 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.18e-08 | 184 | 18 | 5 | 32908313 | |
| Pubmed | 4.77e-08 | 71 | 18 | 4 | 33541421 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.04e-07 | 86 | 18 | 4 | 28327460 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.41e-07 | 248 | 18 | 5 | 24006456 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.54e-07 | 21 | 18 | 3 | 21337463 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.69e-07 | 97 | 18 | 4 | 27559042 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 28252045 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 34445520 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 27487140 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 14991768 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 25393517 | ||
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 2.53e-07 | 2 | 18 | 2 | 24484584 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 9045712 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 24867584 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 17154366 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 24877199 | ||
| Pubmed | 3.71e-07 | 118 | 18 | 4 | 21078624 | ||
| Pubmed | Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis. | 7.59e-07 | 3 | 18 | 2 | 18653767 | |
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 17293099 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 12429738 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 21540769 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 15611103 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 12413896 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 20301293 | ||
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 11421580 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 1.52e-06 | 4 | 18 | 2 | 11104663 | |
| Pubmed | 1.74e-06 | 46 | 18 | 3 | 20301533 | ||
| Pubmed | 2.25e-06 | 50 | 18 | 3 | 23658023 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 16101684 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 26471266 | ||
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 18685438 | ||
| Pubmed | 3.79e-06 | 6 | 18 | 2 | 19349279 | ||
| Pubmed | 3.79e-06 | 6 | 18 | 2 | 9837937 | ||
| Pubmed | 3.79e-06 | 6 | 18 | 2 | 19182256 | ||
| Pubmed | The tight-skin (Tsk) mutation is closely linked to B2m on mouse chromosome 2. | 3.79e-06 | 6 | 18 | 2 | 8111131 | |
| Pubmed | Notch1 haploinsufficiency causes ascending aortic aneurysms in mice. | 5.30e-06 | 7 | 18 | 2 | 29093270 | |
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 16100012 | ||
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 27256716 | ||
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 19998449 | ||
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 10848613 | ||
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 10930463 | ||
| Pubmed | 5.30e-06 | 7 | 18 | 2 | 12169628 | ||
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 7.07e-06 | 8 | 18 | 2 | 23055981 | |
| Pubmed | Retinal transcriptome of neonatal mice after optic nerve injury. | 7.07e-06 | 8 | 18 | 2 | 37252932 | |
| Pubmed | 9.09e-06 | 9 | 18 | 2 | 23986861 | ||
| Pubmed | 9.09e-06 | 9 | 18 | 2 | 29773651 | ||
| Pubmed | LDL receptor-related protein as a component of the midkine receptor. | 9.09e-06 | 9 | 18 | 2 | 10772929 | |
| Pubmed | 1.44e-05 | 1116 | 18 | 6 | 31753913 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.88e-05 | 101 | 18 | 3 | 23382219 | |
| Pubmed | Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice. | 1.97e-05 | 13 | 18 | 2 | 16207730 | |
| Pubmed | The Mohawk homeobox gene is a critical regulator of tendon differentiation. | 1.97e-05 | 13 | 18 | 2 | 20498044 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.18e-05 | 1201 | 18 | 6 | 35696571 | |
| Pubmed | 2.29e-05 | 14 | 18 | 2 | 15084498 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 2.29e-05 | 14 | 18 | 2 | 17389516 | |
| Pubmed | 2.29e-05 | 14 | 18 | 2 | 15082773 | ||
| Pubmed | 2.65e-05 | 15 | 18 | 2 | 20205790 | ||
| Pubmed | 3.02e-05 | 16 | 18 | 2 | 7633422 | ||
| Pubmed | 3.42e-05 | 17 | 18 | 2 | 21531785 | ||
| Pubmed | Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity. | 3.85e-05 | 18 | 18 | 2 | 18651661 | |
| Pubmed | 3.85e-05 | 18 | 18 | 2 | 10827173 | ||
| Pubmed | A Wnt/Notch/Pax7 signaling network supports tissue integrity in tongue development. | 4.30e-05 | 19 | 18 | 2 | 28438836 | |
| Pubmed | Generation of Distal Renal Segments Involves a Unique Population of Aqp2 + Progenitor Cells. | 4.30e-05 | 19 | 18 | 2 | 34667084 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.47e-05 | 135 | 18 | 3 | 28675934 | |
| Pubmed | 5.51e-05 | 418 | 18 | 4 | 34709266 | ||
| Pubmed | 5.81e-05 | 22 | 18 | 2 | 27527664 | ||
| Pubmed | Netrin 1 directs vascular patterning and maturity in the developing kidney. | 6.36e-05 | 23 | 18 | 2 | 37818607 | |
| Pubmed | 6.49e-05 | 153 | 18 | 3 | 25037231 | ||
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 6.94e-05 | 24 | 18 | 2 | 26116661 | |
| Pubmed | Deficient signaling via Alk2 (Acvr1) leads to bicuspid aortic valve development. | 7.54e-05 | 25 | 18 | 2 | 22536403 | |
| Pubmed | 8.81e-05 | 27 | 18 | 2 | 24586749 | ||
| Pubmed | Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module. | 1.00e-04 | 177 | 18 | 3 | 22560297 | |
| Pubmed | Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. | 1.09e-04 | 30 | 18 | 2 | 21946350 | |
| Pubmed | 1.09e-04 | 30 | 18 | 2 | 20301299 | ||
| Pubmed | 1.17e-04 | 31 | 18 | 2 | 32546759 | ||
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 1.17e-04 | 31 | 18 | 2 | 31550482 | |
| Pubmed | 1.24e-04 | 32 | 18 | 2 | 20610746 | ||
| Pubmed | Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study. | 1.24e-04 | 32 | 18 | 2 | 25189868 | |
| Pubmed | 1.49e-04 | 35 | 18 | 2 | 32281291 | ||
| Pubmed | 1.49e-04 | 35 | 18 | 2 | 30940800 | ||
| Pubmed | 1.49e-04 | 35 | 18 | 2 | 32504627 | ||
| Pubmed | 1.58e-04 | 36 | 18 | 2 | 20587546 | ||
| Pubmed | 1.66e-04 | 210 | 18 | 3 | 16537572 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.70e-04 | 560 | 18 | 4 | 21653829 | |
| Pubmed | 1.95e-04 | 40 | 18 | 2 | 23362348 | ||
| Pubmed | 2.36e-04 | 44 | 18 | 2 | 31273033 | ||
| Pubmed | 2.70e-04 | 47 | 18 | 2 | 11208732 | ||
| Pubmed | 2.93e-04 | 49 | 18 | 2 | 21362503 | ||
| Pubmed | 3.00e-04 | 257 | 18 | 3 | 16335952 | ||
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 3.30e-04 | 52 | 18 | 2 | 30389913 | |
| Pubmed | 3.30e-04 | 52 | 18 | 2 | 26590417 | ||
| Pubmed | Comparative mapping of 50 human chromosome 9 loci in the laboratory mouse. | 3.43e-04 | 53 | 18 | 2 | 7774911 | |
| Pubmed | 3.91e-04 | 1285 | 18 | 5 | 35914814 | ||
| Pubmed | 4.11e-04 | 58 | 18 | 2 | 23284291 | ||
| Interaction | NTN5 interactions | 9.41e-12 | 24 | 17 | 5 | int:NTN5 | |
| Interaction | ZFP41 interactions | 9.12e-10 | 57 | 17 | 5 | int:ZFP41 | |
| Interaction | ZNF74 interactions | 1.58e-08 | 34 | 17 | 4 | int:ZNF74 | |
| Interaction | ZNF408 interactions | 1.04e-07 | 145 | 17 | 5 | int:ZNF408 | |
| Interaction | ZNF707 interactions | 5.01e-07 | 79 | 17 | 4 | int:ZNF707 | |
| Interaction | ZDHHC15 interactions | 3.15e-06 | 125 | 17 | 4 | int:ZDHHC15 | |
| Interaction | TRIM37 interactions | 8.40e-06 | 630 | 17 | 6 | int:TRIM37 | |
| Interaction | ANKRD36B interactions | 1.66e-05 | 60 | 17 | 3 | int:ANKRD36B | |
| Interaction | HRG interactions | 1.92e-05 | 63 | 17 | 3 | int:HRG | |
| Interaction | FBN2 interactions | 2.11e-05 | 65 | 17 | 3 | int:FBN2 | |
| Interaction | IGFL3 interactions | 3.24e-05 | 75 | 17 | 3 | int:IGFL3 | |
| Interaction | MBD1 interactions | 3.51e-05 | 77 | 17 | 3 | int:MBD1 | |
| Interaction | ZNF778 interactions | 3.67e-05 | 11 | 17 | 2 | int:ZNF778 | |
| Interaction | ZNF563 interactions | 4.40e-05 | 12 | 17 | 2 | int:ZNF563 | |
| Interaction | CALCR interactions | 5.20e-05 | 13 | 17 | 2 | int:CALCR | |
| Interaction | IGSF5 interactions | 6.06e-05 | 14 | 17 | 2 | int:IGSF5 | |
| Interaction | CUBN interactions | 6.99e-05 | 15 | 17 | 2 | int:CUBN | |
| Interaction | SCN3A interactions | 7.98e-05 | 16 | 17 | 2 | int:SCN3A | |
| Interaction | DAB1 interactions | 9.37e-05 | 107 | 17 | 3 | int:DAB1 | |
| Interaction | LRP5 interactions | 9.90e-05 | 109 | 17 | 3 | int:LRP5 | |
| Interaction | ZNF224 interactions | 1.26e-04 | 20 | 17 | 2 | int:ZNF224 | |
| Interaction | CACNA1A interactions | 1.42e-04 | 123 | 17 | 3 | int:CACNA1A | |
| Interaction | CFC1 interactions | 1.52e-04 | 126 | 17 | 3 | int:CFC1 | |
| Interaction | THBS1 interactions | 1.56e-04 | 127 | 17 | 3 | int:THBS1 | |
| Interaction | BRD1 interactions | 1.67e-04 | 344 | 17 | 4 | int:BRD1 | |
| Interaction | IKZF2 interactions | 2.15e-04 | 26 | 17 | 2 | int:IKZF2 | |
| Interaction | TNFAIP6 interactions | 2.32e-04 | 27 | 17 | 2 | int:TNFAIP6 | |
| Interaction | PID1 interactions | 2.32e-04 | 27 | 17 | 2 | int:PID1 | |
| Interaction | FEZF1 interactions | 2.50e-04 | 28 | 17 | 2 | int:FEZF1 | |
| Interaction | ZNF517 interactions | 2.68e-04 | 29 | 17 | 2 | int:ZNF517 | |
| Interaction | FBXO2 interactions | 3.29e-04 | 411 | 17 | 4 | int:FBXO2 | |
| Interaction | ITGB1BP1 interactions | 3.48e-04 | 33 | 17 | 2 | int:ITGB1BP1 | |
| Interaction | ANKS1B interactions | 3.70e-04 | 34 | 17 | 2 | int:ANKS1B | |
| Interaction | LPL interactions | 3.92e-04 | 35 | 17 | 2 | int:LPL | |
| Interaction | SOST interactions | 3.92e-04 | 35 | 17 | 2 | int:SOST | |
| Interaction | DLK2 interactions | 4.15e-04 | 36 | 17 | 2 | int:DLK2 | |
| Interaction | LRPAP1 interactions | 4.35e-04 | 180 | 17 | 3 | int:LRPAP1 | |
| Interaction | ZNF17 interactions | 4.38e-04 | 37 | 17 | 2 | int:ZNF17 | |
| Interaction | LDLRAP1 interactions | 4.38e-04 | 37 | 17 | 2 | int:LDLRAP1 | |
| Interaction | EMX2 interactions | 4.87e-04 | 39 | 17 | 2 | int:EMX2 | |
| Interaction | RAB4A interactions | 4.91e-04 | 457 | 17 | 4 | int:RAB4A | |
| Interaction | CCN2 interactions | 5.13e-04 | 40 | 17 | 2 | int:CCN2 | |
| Interaction | JAG1 interactions | 5.39e-04 | 41 | 17 | 2 | int:JAG1 | |
| Interaction | APBB1 interactions | 5.49e-04 | 195 | 17 | 3 | int:APBB1 | |
| Interaction | LRP1 interactions | 5.57e-04 | 196 | 17 | 3 | int:LRP1 | |
| Interaction | ZNF398 interactions | 5.93e-04 | 43 | 17 | 2 | int:ZNF398 | |
| Interaction | DCN interactions | 5.93e-04 | 43 | 17 | 2 | int:DCN | |
| Interaction | ELANE interactions | 7.08e-04 | 47 | 17 | 2 | int:ELANE | |
| Interaction | APBA2 interactions | 7.38e-04 | 48 | 17 | 2 | int:APBA2 | |
| Interaction | DKK2 interactions | 7.69e-04 | 49 | 17 | 2 | int:DKK2 | |
| Interaction | WNT3A interactions | 7.69e-04 | 49 | 17 | 2 | int:WNT3A | |
| Interaction | ODAPH interactions | 7.69e-04 | 49 | 17 | 2 | int:ODAPH | |
| Interaction | FOXD4L6 interactions | 7.69e-04 | 49 | 17 | 2 | int:FOXD4L6 | |
| Interaction | C9orf163 interactions | 8.33e-04 | 51 | 17 | 2 | int:C9orf163 | |
| Interaction | KDM1A interactions | 8.49e-04 | 941 | 17 | 5 | int:KDM1A | |
| Interaction | MFAP5 interactions | 8.66e-04 | 52 | 17 | 2 | int:MFAP5 | |
| Interaction | ZNF669 interactions | 8.66e-04 | 52 | 17 | 2 | int:ZNF669 | |
| Interaction | FOXF2 interactions | 9.34e-04 | 54 | 17 | 2 | int:FOXF2 | |
| Interaction | SERPINE1 interactions | 9.34e-04 | 54 | 17 | 2 | int:SERPINE1 | |
| Interaction | SMOC1 interactions | 9.34e-04 | 54 | 17 | 2 | int:SMOC1 | |
| Interaction | DYRK1A interactions | 9.97e-04 | 552 | 17 | 4 | int:DYRK1A | |
| Interaction | CLU interactions | 1.06e-03 | 245 | 17 | 3 | int:CLU | |
| Interaction | MAPK8IP1 interactions | 1.08e-03 | 58 | 17 | 2 | int:MAPK8IP1 | |
| Interaction | VPS39 interactions | 1.08e-03 | 58 | 17 | 2 | int:VPS39 | |
| Interaction | ZNF331 interactions | 1.27e-03 | 63 | 17 | 2 | int:ZNF331 | |
| Interaction | COL5A1 interactions | 1.35e-03 | 65 | 17 | 2 | int:COL5A1 | |
| Interaction | SPARC interactions | 1.35e-03 | 65 | 17 | 2 | int:SPARC | |
| Interaction | LTBP4 interactions | 1.43e-03 | 67 | 17 | 2 | int:LTBP4 | |
| Interaction | ANAPC10 interactions | 1.48e-03 | 68 | 17 | 2 | int:ANAPC10 | |
| Interaction | CNTN1 interactions | 1.52e-03 | 69 | 17 | 2 | int:CNTN1 | |
| Interaction | PRG2 interactions | 1.64e-03 | 285 | 17 | 3 | int:PRG2 | |
| Interaction | SNX17 interactions | 2.09e-03 | 81 | 17 | 2 | int:SNX17 | |
| Interaction | LTBP2 interactions | 2.29e-03 | 85 | 17 | 2 | int:LTBP2 | |
| Interaction | LRP1B interactions | 2.29e-03 | 85 | 17 | 2 | int:LRP1B | |
| Interaction | SIRPD interactions | 2.35e-03 | 86 | 17 | 2 | int:SIRPD | |
| Interaction | PDGFB interactions | 2.46e-03 | 88 | 17 | 2 | int:PDGFB | |
| Interaction | ASPSCR1 interactions | 2.51e-03 | 89 | 17 | 2 | int:ASPSCR1 | |
| Interaction | ZNF324B interactions | 2.51e-03 | 89 | 17 | 2 | int:ZNF324B | |
| Interaction | LGALS1 interactions | 2.54e-03 | 332 | 17 | 3 | int:LGALS1 | |
| Interaction | LAMB3 interactions | 2.57e-03 | 90 | 17 | 2 | int:LAMB3 | |
| Interaction | MDK interactions | 2.62e-03 | 91 | 17 | 2 | int:MDK | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.06e-02 | 1192 | 18 | 3 | chr19q13 | |
| GeneFamily | Low density lipoprotein receptors | 1.05e-07 | 13 | 14 | 3 | 634 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 3.34e-06 | 4 | 14 | 2 | 628 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.64e-02 | 718 | 14 | 3 | 28 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.55e-07 | 191 | 18 | 5 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.76e-07 | 196 | 18 | 5 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 8.58e-07 | 270 | 18 | 5 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 9.39e-07 | 275 | 18 | 5 | M5884 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 8.21e-06 | 194 | 18 | 4 | M39122 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 8.63e-06 | 59 | 18 | 3 | M47993 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 9.08e-06 | 199 | 18 | 4 | M7420 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN | 9.26e-06 | 200 | 18 | 4 | M9657 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 9.26e-06 | 200 | 18 | 4 | M5930 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 2.44e-05 | 11 | 18 | 2 | M566 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.63e-05 | 261 | 18 | 4 | M1834 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 3.18e-05 | 91 | 18 | 3 | M40180 | |
| Coexpression | NABA_MATRISOME | 3.97e-05 | 1008 | 18 | 6 | MM17056 | |
| Coexpression | NABA_MATRISOME | 4.39e-05 | 1026 | 18 | 6 | M5889 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 6.74e-05 | 117 | 18 | 3 | M39300 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 7.12e-05 | 337 | 18 | 4 | MM16606 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 7.44e-05 | 121 | 18 | 3 | M12828 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 7.55e-05 | 681 | 18 | 5 | M39175 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP | 8.40e-05 | 20 | 18 | 2 | MM706 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP | 8.40e-05 | 20 | 18 | 2 | M11701 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 8.71e-05 | 355 | 18 | 4 | M45758 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 9.64e-05 | 132 | 18 | 3 | MM465 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.08e-04 | 137 | 18 | 3 | M40313 | |
| Coexpression | HALLMARK_COAGULATION | 1.10e-04 | 138 | 18 | 3 | M5946 | |
| Coexpression | JEON_SMAD6_TARGETS_UP | 1.22e-04 | 24 | 18 | 2 | M4592 | |
| Coexpression | AZARE_STAT3_TARGETS | 1.22e-04 | 24 | 18 | 2 | M2312 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_UP | 1.35e-04 | 398 | 18 | 4 | M4872 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_AIRWAY_FIBROBLAST | 1.55e-04 | 27 | 18 | 2 | M45665 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.79e-04 | 29 | 18 | 2 | MM17055 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN | 1.92e-04 | 30 | 18 | 2 | M3034 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 1.97e-04 | 439 | 18 | 4 | M39054 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN | 2.18e-04 | 32 | 18 | 2 | MM472 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 2.33e-04 | 178 | 18 | 3 | M17079 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 2.61e-04 | 35 | 18 | 2 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.61e-04 | 35 | 18 | 2 | M11788 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.75e-04 | 479 | 18 | 4 | M2573 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.77e-04 | 36 | 18 | 2 | MM1212 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.84e-04 | 483 | 18 | 4 | MM1082 | |
| Coexpression | VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 | 2.92e-04 | 37 | 18 | 2 | M16643 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 2.96e-04 | 193 | 18 | 3 | M39321 | |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP | 3.05e-04 | 195 | 18 | 3 | M6899 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_MELANOMA | 3.09e-04 | 38 | 18 | 2 | M47982 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP | 3.28e-04 | 200 | 18 | 3 | M9633 | |
| Coexpression | GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 3.28e-04 | 200 | 18 | 3 | M9677 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_UP | 3.28e-04 | 200 | 18 | 3 | M3584 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN | 3.28e-04 | 200 | 18 | 3 | M4386 | |
| Coexpression | CUI_DEVELOPING_HEART_C5_VALVAR_CELL | 3.53e-04 | 205 | 18 | 3 | M39302 | |
| Coexpression | PARK_HSC_MARKERS | 4.14e-04 | 44 | 18 | 2 | M6509 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 4.87e-04 | 229 | 18 | 3 | MM16607 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 5.21e-04 | 567 | 18 | 4 | M2129 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 5.35e-04 | 50 | 18 | 2 | M1259 | |
| Coexpression | LUI_THYROID_CANCER_CLUSTER_1 | 5.79e-04 | 52 | 18 | 2 | M2135 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 5.79e-04 | 52 | 18 | 2 | MM1118 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN | 6.24e-04 | 54 | 18 | 2 | M5312 | |
| Coexpression | HALLMARK_TGF_BETA_SIGNALING | 6.24e-04 | 54 | 18 | 2 | M5896 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 6.44e-04 | 600 | 18 | 4 | M39055 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN | 6.95e-04 | 57 | 18 | 2 | MM463 | |
| Coexpression | KOYAMA_SEMA3B_TARGETS_UP | 7.70e-04 | 268 | 18 | 3 | M12746 | |
| Coexpression | KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES | 8.21e-04 | 274 | 18 | 3 | M2538 | |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN | 8.21e-04 | 274 | 18 | 3 | M289 | |
| Coexpression | TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL | 9.03e-04 | 65 | 18 | 2 | M41673 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 9.29e-04 | 286 | 18 | 3 | M45746 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 9.57e-04 | 289 | 18 | 3 | M41750 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 1.03e-03 | 296 | 18 | 3 | M41675 | |
| Coexpression | KUMAR_AUTOPHAGY_NETWORK | 1.11e-03 | 72 | 18 | 2 | M2539 | |
| Coexpression | LEE_AGING_CEREBELLUM_DN | 1.14e-03 | 73 | 18 | 2 | M1544 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 1.17e-03 | 310 | 18 | 3 | MM16608 | |
| Coexpression | LEE_AGING_CEREBELLUM_DN | 1.20e-03 | 75 | 18 | 2 | MM662 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN | 1.23e-03 | 76 | 18 | 2 | M8315 | |
| Coexpression | HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS | 1.26e-03 | 77 | 18 | 2 | M19128 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 1.28e-03 | 721 | 18 | 4 | M1999 | |
| Coexpression | WONG_ENDMETRIUM_CANCER_DN | 1.30e-03 | 78 | 18 | 2 | M1311 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | 1.31e-03 | 322 | 18 | 3 | MM3786 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.32e-03 | 323 | 18 | 3 | M9150 | |
| Coexpression | FAN_EMBRYONIC_CTX_ASTROCYTE_1 | 1.33e-03 | 79 | 18 | 2 | M39033 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 1.34e-03 | 325 | 18 | 3 | M39053 | |
| Coexpression | WARTERS_RESPONSE_TO_IR_SKIN | 1.47e-03 | 83 | 18 | 2 | M2600 | |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 1.50e-03 | 84 | 18 | 2 | M15484 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 1.57e-03 | 86 | 18 | 2 | M2259 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 1.57e-03 | 86 | 18 | 2 | M39247 | |
| Coexpression | LIU_VAV3_PROSTATE_CARCINOGENESIS_UP | 1.68e-03 | 89 | 18 | 2 | M215 | |
| Coexpression | JONES_OVARY_T_CELL | 1.76e-03 | 91 | 18 | 2 | M48354 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 1.83e-03 | 362 | 18 | 3 | M39176 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.93e-03 | 369 | 18 | 3 | MM16610 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 1.93e-03 | 807 | 18 | 4 | M16651 | |
| Coexpression | ROVERSI_GLIOMA_COPY_NUMBER_UP | 2.12e-03 | 100 | 18 | 2 | M11028 | |
| Coexpression | CAHOY_ASTROGLIAL | 2.12e-03 | 100 | 18 | 2 | M2807 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 2.20e-03 | 102 | 18 | 2 | MM1064 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | 2.29e-03 | 104 | 18 | 2 | M45682 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 9.22e-07 | 91 | 18 | 4 | GSM777059_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.40e-06 | 455 | 18 | 6 | GSM777055_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 1.78e-05 | 408 | 18 | 5 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.48e-05 | 437 | 18 | 5 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 2.53e-05 | 439 | 18 | 5 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.70e-05 | 445 | 18 | 5 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 2.85e-05 | 450 | 18 | 5 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 2.94e-05 | 453 | 18 | 5 | GSM777067_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 3.02e-05 | 778 | 18 | 6 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 3.13e-05 | 783 | 18 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.37e-05 | 466 | 18 | 5 | GSM777050_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 4.34e-05 | 82 | 18 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 5.19e-05 | 87 | 18 | 3 | GSM777050_100 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 6.96e-05 | 96 | 18 | 3 | GSM777063_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 7.17e-05 | 97 | 18 | 3 | GSM777043_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#2 | 8.58e-05 | 103 | 18 | 3 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | 1.05e-04 | 973 | 18 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 1.05e-04 | 973 | 18 | 6 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 1.07e-04 | 976 | 18 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 1.12e-04 | 984 | 18 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.16e-04 | 114 | 18 | 3 | gudmap_kidney_P3_CapMes_Crym_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.16e-04 | 310 | 18 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.17e-04 | 311 | 18 | 4 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.42e-04 | 327 | 18 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.71e-04 | 130 | 18 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.72e-04 | 658 | 18 | 5 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 2.08e-04 | 361 | 18 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.12e-04 | 688 | 18 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.26e-04 | 369 | 18 | 4 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 2.29e-04 | 370 | 18 | 4 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 2.33e-04 | 372 | 18 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 2.36e-04 | 373 | 18 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 2.41e-04 | 146 | 18 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.51e-04 | 379 | 18 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.66e-04 | 722 | 18 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 2.93e-04 | 156 | 18 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 3.02e-04 | 398 | 18 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.03e-04 | 743 | 18 | 5 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.11e-04 | 747 | 18 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.11e-04 | 747 | 18 | 5 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | 3.15e-04 | 749 | 18 | 5 | gudmap_kidney_P3_CapMes_Crym_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 3.45e-04 | 165 | 18 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 3.51e-04 | 166 | 18 | 3 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.64e-04 | 168 | 18 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 3.73e-04 | 777 | 18 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 4.10e-04 | 793 | 18 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 4.10e-04 | 175 | 18 | 3 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | 4.14e-04 | 795 | 18 | 5 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 4.60e-04 | 182 | 18 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 5.06e-04 | 456 | 18 | 4 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 5.18e-04 | 459 | 18 | 4 | GSM777037_500 | |
| CoexpressionAtlas | Mesoderm Day 30_vs_Mesoderm Day 15-Confounder_removed-fold2.0_adjp0.05 | 5.19e-04 | 40 | 18 | 2 | PCBC_ratio_MESO-30_vs_MESO-15_cfr-2X-p05 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.40e-04 | 464 | 18 | 4 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | 5.60e-04 | 849 | 18 | 5 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 5.73e-04 | 42 | 18 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500 | 6.09e-04 | 479 | 18 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | 6.33e-04 | 872 | 18 | 5 | gudmap_kidney_adult_Mesangium_Meis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 6.58e-04 | 489 | 18 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_500 | 7.80e-04 | 49 | 18 | 2 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 9.46e-04 | 54 | 18 | 2 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | 1.01e-03 | 967 | 18 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 1.03e-03 | 240 | 18 | 3 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 1.09e-03 | 983 | 18 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.12e-03 | 247 | 18 | 3 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.22e-03 | 255 | 18 | 3 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#4_top-relative-expression-ranked_200 | 1.25e-03 | 62 | 18 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_200_k4 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 1.25e-03 | 62 | 18 | 2 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.29e-03 | 63 | 18 | 2 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.37e-03 | 265 | 18 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#4 | 1.45e-03 | 67 | 18 | 2 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K4 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.LN, F480+ Ly6c+ MHCII lo/+, Lymph Node, avg-3 | 1.50e-03 | 68 | 18 | 2 | GSM605875_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.53e-03 | 614 | 18 | 4 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3 | 1.54e-03 | 69 | 18 | 2 | GSM605872_100 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 1.54e-03 | 69 | 18 | 2 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - stomach cardiac | 1.67e-03 | 72 | 18 | 2 | BM Top 100 - stomach cardiac | |
| CoexpressionAtlas | Myeloid Cells, MF.Lv, CD45+ F4/80+ CD11b+, Liver, avg-2 | 1.67e-03 | 72 | 18 | 2 | GSM854320_100 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_1000 | 1.75e-03 | 636 | 18 | 4 | gudmap_kidney_P2_CapMes_Crym_1000 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_1000 | 1.78e-03 | 639 | 18 | 4 | gudmap_kidney_P0_CapMes_Crym_1000 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | 1.84e-03 | 294 | 18 | 3 | gudmap_kidney_P0_CapMes_Crym_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.86e-03 | 295 | 18 | 3 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K1 | |
| CoexpressionAtlas | Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3 | 1.91e-03 | 77 | 18 | 2 | GSM854294_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.93e-03 | 654 | 18 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 2.11e-03 | 81 | 18 | 2 | GSM605865_100 | |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_top-relative-expression-ranked_100 | 2.11e-03 | 81 | 18 | 2 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_100 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_100 | 2.17e-03 | 82 | 18 | 2 | gudmap_kidney_e15.5_Podocyte_MafB_100 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | 2.17e-03 | 1148 | 18 | 5 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.27e-03 | 683 | 18 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 2.27e-03 | 84 | 18 | 2 | GSM605862_100 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 2.32e-03 | 85 | 18 | 2 | GSM777067_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 2.38e-03 | 86 | 18 | 2 | GSM605850_100 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_100 | 2.43e-03 | 87 | 18 | 2 | gudmap_kidney_P0_JuxtaGlom_Ren1_100 | |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | 2.43e-03 | 87 | 18 | 2 | GSM791122_100 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_100 | 2.54e-03 | 89 | 18 | 2 | gudmap_kidney_P3_CapMes_Crym_100 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_100 | 2.54e-03 | 89 | 18 | 2 | gudmap_kidney_P4_CapMesRenVes_Crym_100 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.69e-03 | 336 | 18 | 3 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.69e-03 | 336 | 18 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.71e-03 | 337 | 18 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 2.72e-03 | 92 | 18 | 2 | GSM791126_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#4 | 2.72e-03 | 92 | 18 | 2 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.72e-03 | 92 | 18 | 2 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K5 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 9.42e-13 | 200 | 18 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.03e-11 | 189 | 18 | 6 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.06e-10 | 194 | 18 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.23e-10 | 199 | 18 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.23e-10 | 199 | 18 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.27e-10 | 200 | 18 | 6 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.27e-10 | 200 | 18 | 6 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.27e-10 | 200 | 18 | 6 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.74e-09 | 179 | 18 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.19e-09 | 181 | 18 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.13e-09 | 185 | 18 | 5 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.64e-09 | 187 | 18 | 5 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.64e-09 | 187 | 18 | 5 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.90e-09 | 188 | 18 | 5 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.90e-09 | 188 | 18 | 5 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-08 | 189 | 18 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.02e-08 | 189 | 18 | 5 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-08 | 189 | 18 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-08 | 190 | 18 | 5 | d13fd234caa3fc69d8a59bc0060cdacdf716ee55 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.07e-08 | 191 | 18 | 5 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-08 | 191 | 18 | 5 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-08 | 191 | 18 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-08 | 191 | 18 | 5 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-08 | 191 | 18 | 5 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-08 | 192 | 18 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-08 | 192 | 18 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.10e-08 | 192 | 18 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-08 | 192 | 18 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-08 | 192 | 18 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-08 | 192 | 18 | 5 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-08 | 192 | 18 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-08 | 192 | 18 | 5 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-08 | 193 | 18 | 5 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-08 | 193 | 18 | 5 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-08 | 194 | 18 | 5 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-08 | 194 | 18 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-08 | 194 | 18 | 5 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-08 | 194 | 18 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.16e-08 | 194 | 18 | 5 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-08 | 195 | 18 | 5 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | COVID-19-Heart-Low_count_Fib|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-08 | 195 | 18 | 5 | e09590d1f51d5fa57fceb84c9f48f84b23d4d224 | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.19e-08 | 195 | 18 | 5 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | P03-Mesenchymal|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.19e-08 | 195 | 18 | 5 | 6180309c6ae278b996fd98c57461cbc129c028ba | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-08 | 196 | 18 | 5 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-08 | 196 | 18 | 5 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-08 | 196 | 18 | 5 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.25e-08 | 197 | 18 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Airway_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.25e-08 | 197 | 18 | 5 | 233caeee200ca905900226f85426e084caf290fb | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-08 | 197 | 18 | 5 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-08 | 197 | 18 | 5 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.32e-08 | 199 | 18 | 5 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.32e-08 | 199 | 18 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.32e-08 | 199 | 18 | 5 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.32e-08 | 199 | 18 | 5 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.32e-08 | 199 | 18 | 5 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.32e-08 | 199 | 18 | 5 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.32e-08 | 199 | 18 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 1.32e-08 | 199 | 18 | 5 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.32e-08 | 199 | 18 | 5 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.35e-08 | 200 | 18 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.35e-08 | 200 | 18 | 5 | ab4fda0cc95cb8f80ea9f28745013f3248def820 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.35e-08 | 200 | 18 | 5 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-08 | 200 | 18 | 5 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.35e-08 | 200 | 18 | 5 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.35e-08 | 200 | 18 | 5 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.35e-08 | 200 | 18 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-08 | 200 | 18 | 5 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-08 | 200 | 18 | 5 | c5d818203bef80ff97c2e0158cf61970673dd258 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.35e-08 | 200 | 18 | 5 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.35e-08 | 200 | 18 | 5 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-08 | 200 | 18 | 5 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-07 | 171 | 18 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.19e-07 | 173 | 18 | 4 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-07 | 175 | 18 | 4 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-07 | 175 | 18 | 4 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-07 | 175 | 18 | 4 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-07 | 176 | 18 | 4 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-07 | 176 | 18 | 4 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.42e-07 | 181 | 18 | 4 | 091e7975badd1ffa463a8ec87908be20781ecfd6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-07 | 181 | 18 | 4 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-07 | 181 | 18 | 4 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.58e-07 | 182 | 18 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.58e-07 | 182 | 18 | 4 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.58e-07 | 182 | 18 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.58e-07 | 182 | 18 | 4 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.58e-07 | 182 | 18 | 4 | da3e9093cba791c7c282eb044656046252a32789 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.58e-07 | 182 | 18 | 4 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.75e-07 | 183 | 18 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.75e-07 | 183 | 18 | 4 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.92e-07 | 184 | 18 | 4 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 7.92e-07 | 184 | 18 | 4 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.09e-07 | 185 | 18 | 4 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.09e-07 | 185 | 18 | 4 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.09e-07 | 185 | 18 | 4 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.09e-07 | 185 | 18 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.09e-07 | 185 | 18 | 4 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-07 | 186 | 18 | 4 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.27e-07 | 186 | 18 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.27e-07 | 186 | 18 | 4 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.45e-07 | 187 | 18 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| Computational | ECM and collagens. | 2.05e-07 | 225 | 14 | 6 | MODULE_47 | |
| Computational | Metal / Ca ion binding. | 6.10e-04 | 133 | 14 | 3 | MODULE_324 | |
| Computational | Ovary genes. | 1.03e-03 | 368 | 14 | 4 | MODULE_1 | |
| Computational | DRG (dorsal root ganglia) genes. | 1.21e-03 | 384 | 14 | 4 | MODULE_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Drug | monatepil | 1.50e-06 | 29 | 18 | 3 | CID000060810 | |
| Drug | pyrachlostrobin | 1.60e-06 | 811 | 18 | 7 | ctd:C513428 | |
| Drug | funiferine N-oxide | 7.47e-06 | 49 | 18 | 3 | CID000191631 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 8.26e-06 | 373 | 18 | 5 | ctd:C540355 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.48e-05 | 196 | 18 | 4 | 3847_UP | |
| Drug | F0447-0125; Up 200; 10uM; PC3; HT_HG-U133A | 1.48e-05 | 196 | 18 | 4 | 6401_UP | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.51e-05 | 197 | 18 | 4 | 6277_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.61e-05 | 200 | 18 | 4 | 3714_UP | |
| Drug | coprogen | 2.12e-05 | 9 | 18 | 2 | CID006323272 | |
| Drug | 25-azacoprostane | 2.65e-05 | 10 | 18 | 2 | CID000162243 | |
| Drug | pitavastatin | 9.44e-05 | 114 | 18 | 3 | CID005282451 | |
| Drug | HepI | 1.11e-04 | 20 | 18 | 2 | CID003036968 | |
| Drug | Epi Lovastatin | 1.28e-04 | 341 | 18 | 4 | CID000003962 | |
| Drug | Hymecromone | 1.75e-04 | 25 | 18 | 2 | ctd:D006923 | |
| Drug | ezetimibe | 2.00e-04 | 147 | 18 | 3 | CID000150311 | |
| Drug | simvastatin | 2.14e-04 | 390 | 18 | 4 | CID000054454 | |
| Drug | tetrahydroaldosterone-3-glucuronide | 2.37e-04 | 29 | 18 | 2 | CID000167918 | |
| Drug | sodium cholate | 2.55e-04 | 408 | 18 | 4 | CID000000303 | |
| Drug | 25-hydroxycholesterol | 2.57e-04 | 160 | 18 | 3 | CID000065094 | |
| Drug | probucol | 2.67e-04 | 162 | 18 | 3 | CID000004912 | |
| Drug | 2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide | 2.71e-04 | 31 | 18 | 2 | ctd:C577942 | |
| Drug | pimobendan | 2.89e-04 | 32 | 18 | 2 | CID000004823 | |
| Drug | uPA inhibitor | 2.89e-04 | 32 | 18 | 2 | CID000001746 | |
| Drug | AC1NAG0I | 2.89e-04 | 32 | 18 | 2 | CID004476319 | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; HL60; HT_HG-U133A | 3.35e-04 | 175 | 18 | 3 | 2507_UP | |
| Drug | beta-Naphthoflavone | 3.63e-04 | 828 | 18 | 5 | ctd:D019324 | |
| Drug | AC1L9GQC | 3.87e-04 | 37 | 18 | 2 | CID000444689 | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; PC3; HT_HG-U133A | 4.06e-04 | 187 | 18 | 3 | 7402_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 4.26e-04 | 190 | 18 | 3 | 5223_DN | |
| Drug | 0393-0188; Up 200; 10uM; PC3; HT_HG-U133A | 4.39e-04 | 192 | 18 | 3 | 7536_UP | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HT_HG-U133A | 4.46e-04 | 193 | 18 | 3 | 4650_DN | |
| Drug | Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.46e-04 | 193 | 18 | 3 | 3344_UP | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 4.46e-04 | 193 | 18 | 3 | 5584_DN | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 4.46e-04 | 193 | 18 | 3 | 1464_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 3422_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Up 200; 17uM; PC3; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 4538_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 3812_UP | |
| Drug | Gliquidone [33342-05-1]; Up 200; 7.6uM; HL60; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 3126_UP | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; HL60; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 2998_UP | |
| Drug | 15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 4455_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 3456_UP | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 4345_DN | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 7559_UP | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 5591_DN | |
| Drug | Azapropazone [13539-59-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 6522_DN | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 3986_UP | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; HL60; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 2174_UP | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 3375_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 3817_UP | |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 6605_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 3371_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 5604_DN | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 6435_UP | |
| Drug | clozapine; Up 200; 10uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 4453_UP | |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 4154_UP | |
| Drug | Isosorbide dinitrate [87-33-2]; Up 200; 17uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 3720_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 6180_UP | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 4137_DN | |
| Drug | Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 1486_DN | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 6758_DN | |
| Drug | Trimethadione [127-48-0]; Up 200; 28uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 4165_UP | |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 3399_DN | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 4181_UP | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; HL60; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 2361_UP | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; HL60; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 3000_UP | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 2212_DN | |
| Drug | Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5823_UP | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 1508_DN | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5630_UP | |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 4418_UP | |
| Drug | PF-00539745-00 [351321-33-0]; Up 200; 10uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5939_UP | |
| Drug | Diloxanide furoate [3736-81-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 6679_UP | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 4077_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 4465_UP | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 6043_UP | |
| Drug | Bisacodyl [603-50-9]; Up 200; 11uM; HL60; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 2435_UP | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 5729_DN | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 3419_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 5108_UP | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 2107_UP | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 6395_DN | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 4358_UP | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 6637_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 5865_UP | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 3739_UP | |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 5104_UP | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 1uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 4562_UP | |
| Drug | rotenone; Up 200; 1uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 5948_UP | |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; PC3; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 4087_DN | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 5804_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; HL60; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 2555_UP | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 5541_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 6466_UP | |
| Drug | Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 4692_UP | |
| Drug | Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 3167_UP | |
| Drug | scopolamine | 4.94e-04 | 200 | 18 | 3 | CID000005184 | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; HL60; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 3145_UP | |
| Drug | CS-0398 | 5.48e-04 | 44 | 18 | 2 | CID005288149 | |
| Drug | Rp-8-Br-cGMPS | 5.99e-04 | 46 | 18 | 2 | CID003035839 | |
| Drug | troglitazone | 6.66e-04 | 526 | 18 | 4 | CID000005591 | |
| Disease | Weill-Marchesani syndrome | 1.05e-06 | 3 | 18 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 1.05e-06 | 3 | 18 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 1.05e-06 | 3 | 18 | 2 | C1869114 | |
| Disease | Weill-Marchesani syndrome | 2.11e-06 | 4 | 18 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 2.11e-06 | 4 | 18 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | aortic aneurysm | 1.58e-05 | 10 | 18 | 2 | EFO_0001666 | |
| Disease | Marfan Syndrome | 1.93e-05 | 11 | 18 | 2 | C0024796 | |
| Disease | FEV/FEC ratio | 6.19e-05 | 1228 | 18 | 6 | EFO_0004713 | |
| Disease | vital capacity | 6.42e-05 | 1236 | 18 | 6 | EFO_0004312 | |
| Disease | Splenomegaly | 8.06e-05 | 22 | 18 | 2 | C0038002 | |
| Disease | urate measurement | 1.57e-04 | 895 | 18 | 5 | EFO_0004531 | |
| Disease | spontaneous coronary artery dissection | 1.62e-04 | 31 | 18 | 2 | EFO_0010820 | |
| Disease | attempted suicide | 1.65e-04 | 178 | 18 | 3 | EFO_0004321 | |
| Disease | pack-years measurement, systolic blood pressure | 1.95e-04 | 34 | 18 | 2 | EFO_0006335, EFO_0006526 | |
| Disease | intraocular pressure measurement | 2.21e-04 | 509 | 18 | 4 | EFO_0004695 | |
| Disease | cortical thickness | 4.30e-04 | 1113 | 18 | 5 | EFO_0004840 | |
| Disease | aortic measurement | 4.52e-04 | 251 | 18 | 3 | EFO_0020865 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 4.58e-04 | 52 | 18 | 2 | C0023452 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.75e-04 | 53 | 18 | 2 | C4707243 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LEDTCRRQDFNPCEY | 36 | Q9BZE9 | |
| NDDQLLFCDDCDRGY | 336 | Q92782 | |
| DPDCEGHRCENGVYD | 741 | P78312 | |
| PDIHEERQYRCEDCD | 201 | Q03112 | |
| SPCRNGGECRQSEDY | 836 | P46531 | |
| ANDCGDYSDERDCPG | 2676 | Q07954 | |
| RDCPDGADENDCQYP | 131 | P98164 | |
| YNDCGDNSDERDCEM | 3781 | P98164 | |
| RDPLECNICGYRSQD | 496 | Q9UKS7 | |
| RPSGYVCRQEGNECD | 451 | Q9UKF2 | |
| PNQDECLDNREGYCF | 2326 | P35555 | |
| CPDYEFRENCGLNDH | 51 | Q9H665 | |
| SQAYCTDDNECLRDP | 881 | Q14767 | |
| RECYFDTAAPDACDN | 1181 | Q8N2S1 | |
| DRDDVGDRCDNCPYN | 766 | P07996 | |
| CVDCEAGSYRQNPDD | 521 | Q7RTX0 | |
| YTGEDCRDRQCPRDC | 491 | P24821 | |
| GYADRRPCESNECGN | 266 | Q86TJ5 | |
| EEDEFPCQNGYCIRS | 111 | O75096 |